This inventor holds 1 USPTO granted patent. Top assignee: Farmitalia Carlo Erba S.r.l.. Active years: 1994.
Company Filing History:
Years Active: 1994
Title: Nuccia Oneto: Innovator in Angiogenesis Inhibition
Introduction
Nuccia Oneto is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as angiogenesis inhibitors. Her work is crucial in the fight against metastasis in cancer treatment.
Latest Patents
Nuccia Oneto holds a patent for 3-deoxy-mannosamine derivatives. This invention relates to 3-deoxy-derivatives of D-mannosamine, which are useful as angiogenesis inhibitors. The patent describes compounds of the formula wherein R can be --NH₂ or a C₂-C₅ alkanoyl-NH-- or CF₃CONH-- group. The invention also specifies that R₁ and R₂ can be various alkyl groups or other specified elements, making these compounds valuable in pharmaceutical applications.
Career Highlights
Nuccia Oneto is associated with Farmitalia Carlo Erba S.r.l., where she has been instrumental in advancing research and development in her field. Her innovative approach and dedication to her work have positioned her as a key figure in pharmaceutical research.
Collaborations
Nuccia collaborates with notable colleagues such as Nicola Mongelli and Alberto Bargiotti. These partnerships enhance her research capabilities and contribute to the success of her projects.
Conclusion
Nuccia Oneto's contributions to the field of pharmaceuticals, particularly through her patent on 3-deoxy-mannosamine derivatives, highlight her role as an innovator in angiogenesis inhibition. Her work continues to impact cancer treatment and research positively.